针对端粒动态作为一种有效的方法来开发癌症治疗方法
Hong-Yu Tao1, Chun-Yan Zhao1, Ying Wang1
1Laboratory of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
International journal of nanomedicine
|May 6, 2024
概括
针对端粒动态为癌症治疗提供了一个有希望的策略,通过激活免疫反应和缩短端粒. 这些药物显示出化学疗法,免疫疗法以及向癌症干细胞的潜力.
科学领域:
- 遗传学和分子生物学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 端粒对于真核生物的基因组完整性和稳定性至关重要.
- 端粒功能障碍与癌症进展有关.
- 准端粒动态为癌症治疗提供了一个新的治疗途径.
研究的目的:
- 在临床前和临床研究中审查针对端粒动态的药物.
- 突出这些药物在癌症治疗中的治疗潜力.
- 探索包括免疫反应激活和端粒缩短在内的机制.
主要方法:
- 对以端粒动态为向剂的临床前研究和临床试验的审查.
- 对分子机制的分析,包括免疫反应和端粒长度调制.
- 研究药物输送系统,如纳米粒子和抗体合物.
主要成果:
- 端粒动态活性剂证明了作为化疗剂和免疫治疗剂的有效性.
- 这些药物显示出向癌症干细胞的潜力.
- 与瘤特异性药物输送系统的整合提高了疗效.
结论:
- 准端粒动态是开发新型癌症疗法的有希望的策略.
- 这些药物提供了多方面的抗癌作用机制.
- 组合疗法和有针对性的输送系统可以改善治疗结果.
相关概念视频
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Telomeres and Telomerase
23.3K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Replication in Eukaryotes
13.7K
In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
13.7K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


